Hence, Dupixent is an effective alternative for moderate to severe EoE patients who failed with conventional treatment options. Eohilia (Budesonide oral suspension): Takeda Eohilia (Budesonide oral ...

Meanwhile, in July the FDA missed its review deadline for Takeda's Eohilia (budesonide oral suspension) treatment for the inflammatory disease eosinophilic oesophagitis, while the EMA extended the ...

The US regulator has cleared Eohilia (formerly TAK-721), an oral suspension formulation of the well-established steroid drug budesonide, for people 11 years and older with EoE after turning down ...

Pharmacist order entry was identified as one of the factors contributing to medication errors on the NICU. The availability of products in multiple strengths provided pharmacists the opportunity ...